ALNYLAM PHARMACEUTICALS, INC. Stock-Based Compensation
ALNYLAM PHARMACEUTICALS, INC. (ALNY) reported Stock-Based Compensation of $156.78 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-07-30
- ALNYLAM PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $71.63M, a 21.84% decline year-over-year.
- ALNYLAM PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $108.21M, a 136.25% increase year-over-year.
- ALNYLAM PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-06-30 was $111.68M, a 25.08% increase year-over-year.
- ALNYLAM PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-03-31 was $56.71M, a 25.06% increase year-over-year.
- ALNYLAM PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $348.24M, a 27.99% increase from fiscal 2024.
- ALNYLAM PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $272.08M, a 22.74% increase from fiscal 2023.
- ALNYLAM PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $221.68M, a 3.89% decline from fiscal 2022.
- ALNYLAM PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $230.65M, a 39.18% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $156.78M 10-Q · filed 2026-07-30 | |||
| 2025-12-31 | $71.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $179.84M derived: sum of 2 quarters · filed 2026-02-12 | $291.52M derived: sum of 3 quarters · filed 2026-07-30 | $348.24M 10-K · filed 2026-02-12 |
| 2025-09-30 | $108.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $219.89M derived: sum of 2 quarters · filed 2026-07-30 | $276.60M 10-Q · filed 2025-10-30 | $368.25M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $111.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $168.39M 10-Q · filed 2026-07-30 | $260.04M derived: sum of 3 quarters · filed 2026-07-30 | $305.84M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $56.71M 10-Q · filed 2025-05-01 | $148.36M derived: sum of 2 quarters · filed 2026-02-12 | $194.16M derived: sum of 3 quarters · filed 2026-02-12 | $283.45M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-12-31 | $91.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $137.45M derived: sum of 2 quarters · filed 2026-02-12 | $226.74M derived: sum of 3 quarters · filed 2026-02-12 | $272.08M 10-K · filed 2026-02-12 |
| 2024-09-30 | $45.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $135.09M derived: sum of 2 quarters · filed 2025-10-30 | $180.44M 10-Q · filed 2025-10-30 | $222.43M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-06-30 | $89.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $134.63M 10-Q · filed 2025-07-31 | $176.63M derived: sum of 3 quarters · filed 2026-02-12 | $240.57M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-03-31 | $45.35M 10-Q · filed 2025-05-01 | $87.34M derived: sum of 2 quarters · filed 2026-02-12 | $151.28M derived: sum of 3 quarters · filed 2026-02-12 | $227.08M derived: sum of 4 quarters · filed 2026-02-12 |
| 2023-12-31 | $41.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $105.93M derived: sum of 2 quarters · filed 2026-02-12 | $181.73M derived: sum of 3 quarters · filed 2026-02-12 | $221.68M 10-K · filed 2026-02-12 |
| 2023-09-30 | $63.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $139.74M derived: sum of 2 quarters · filed 2024-10-31 | $179.69M 10-Q · filed 2024-10-31 | $222.45M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | $75.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $115.75M 10-Q · filed 2024-08-01 | $158.52M derived: sum of 3 quarters · filed 2025-02-13 | $286.63M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | $39.95M 10-Q · filed 2024-05-02 | $82.71M derived: sum of 2 quarters · filed 2025-02-13 | $210.83M derived: sum of 3 quarters · filed 2025-02-13 | $241.30M derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | $42.77M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $170.88M derived: sum of 2 quarters · filed 2025-02-13 | $201.36M derived: sum of 3 quarters · filed 2025-02-13 | $230.65M 10-K · filed 2025-02-13 |
| 2022-09-30 | $128.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $158.59M derived: sum of 2 quarters · filed 2023-11-02 | $187.88M 10-Q · filed 2023-11-02 | $232.46M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | $30.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $59.76M 10-Q · filed 2023-08-03 | $104.35M derived: sum of 3 quarters · filed 2024-02-15 | $137.71M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | $29.29M 10-Q · filed 2023-05-04 | $73.88M derived: sum of 2 quarters · filed 2024-02-15 | $107.24M derived: sum of 3 quarters · filed 2024-02-15 | $139.32M derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | $44.58M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $77.95M derived: sum of 2 quarters · filed 2024-02-15 | $110.03M derived: sum of 3 quarters · filed 2024-02-15 | $165.72M 10-K · filed 2024-02-15 |
| 2021-09-30 | $33.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $65.44M derived: sum of 2 quarters · filed 2022-10-27 | $121.14M 10-Q · filed 2022-10-27 | $155.41M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $32.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-28 | $87.77M 10-Q · filed 2022-07-28 | $122.04M derived: sum of 3 quarters · filed 2023-02-23 | $159.31M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $55.69M 10-Q · filed 2022-04-28 | $89.97M derived: sum of 2 quarters · filed 2023-02-23 | $127.23M derived: sum of 3 quarters · filed 2023-02-23 | $160.99M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $34.28M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $71.54M derived: sum of 2 quarters · filed 2023-02-23 | $105.30M derived: sum of 3 quarters · filed 2023-02-23 | $139.87M 10-K · filed 2023-02-23 |
| 2020-09-30 | $37.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $71.02M derived: sum of 2 quarters · filed 2021-10-28 | $105.60M 10-Q · filed 2021-10-28 | $171.79M derived: sum of 4 quarters · filed 2022-02-10 |
| 2020-06-30 | $33.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $68.33M 10-Q · filed 2021-08-03 | $134.53M derived: sum of 3 quarters · filed 2022-02-10 | $180.54M derived: sum of 4 quarters · filed 2022-02-10 |
| 2020-03-31 | $34.58M 10-Q · filed 2021-04-29 | $100.78M derived: sum of 2 quarters · filed 2022-02-10 | $146.78M derived: sum of 3 quarters · filed 2022-02-10 | $177.39M derived: sum of 4 quarters · filed 2022-02-10 |
| 2019-12-31 | $66.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-10 | $112.21M derived: sum of 2 quarters · filed 2022-02-10 | $142.81M derived: sum of 3 quarters · filed 2022-02-10 | $174.84M 10-K · filed 2022-02-10 |
| 2019-09-30 | $46.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $76.61M derived: sum of 2 quarters · filed 2020-11-05 | $108.64M 10-Q · filed 2020-11-05 | $136.62M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-06-30 | $30.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $62.63M 10-Q · filed 2020-08-06 | $90.61M derived: sum of 3 quarters · filed 2021-02-11 | $178.56M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-03-31 | $32.03M 10-Q · filed 2020-05-06 | $60.01M derived: sum of 2 quarters · filed 2021-02-11 | $147.96M derived: sum of 3 quarters · filed 2021-02-11 | $170.20M derived: sum of 4 quarters · filed 2021-02-11 |
| 2018-12-31 | $27.97M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $115.93M derived: sum of 2 quarters · filed 2021-02-11 | $138.17M derived: sum of 3 quarters · filed 2021-02-11 | $157.75M 10-K · filed 2021-02-11 |
| 2018-09-30 | $87.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $110.19M derived: sum of 2 quarters · filed 2019-10-31 | $129.78M 10-Q · filed 2019-10-31 | $156.90M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $22.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $41.83M 10-Q · filed 2019-08-06 | $68.94M derived: sum of 3 quarters · filed 2020-02-13 | $94.90M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | $19.58M 10-Q · filed 2019-05-02 | $46.70M derived: sum of 2 quarters · filed 2020-02-13 | $72.66M derived: sum of 3 quarters · filed 2020-02-13 | $96.69M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | $27.12M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $53.07M derived: sum of 2 quarters · filed 2020-02-13 | $77.10M derived: sum of 3 quarters · filed 2020-02-13 | $92.82M 10-K · filed 2020-02-13 |
| 2017-09-30 | $25.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $49.98M derived: sum of 2 quarters · filed 2018-11-07 | $65.70M 10-Q · filed 2018-11-07 | $86.35M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-06-30 | $24.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $39.75M 10-Q · filed 2018-08-02 | $60.40M derived: sum of 3 quarters · filed 2019-02-14 | $75.98M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-03-31 | $15.72M 10-Q · filed 2018-05-04 | $36.37M derived: sum of 2 quarters · filed 2019-02-14 | $51.95M derived: sum of 3 quarters · filed 2019-02-14 | $67.77M derived: sum of 4 quarters · filed 2019-02-14 |
| 2016-12-31 | $20.65M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $36.23M derived: sum of 2 quarters · filed 2019-02-14 | $52.05M derived: sum of 3 quarters · filed 2019-02-14 | $75.53M 10-K · filed 2019-02-14 |
| 2016-09-30 | $15.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $31.40M derived: sum of 2 quarters · filed 2017-11-07 | $54.88M 10-Q · filed 2017-11-07 | $70.40M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-06-30 | $15.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $39.30M 10-Q · filed 2017-08-09 | $54.82M derived: sum of 3 quarters · filed 2018-02-15 | $66.66M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-03-31 | $23.48M 10-Q · filed 2017-05-05 | $39.00M derived: sum of 2 quarters · filed 2018-02-15 | $50.85M derived: sum of 3 quarters · filed 2018-02-15 | $61.03M derived: sum of 4 quarters · filed 2018-02-15 |
| 2015-12-31 | $15.52M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $27.37M derived: sum of 2 quarters · filed 2018-02-15 | $37.55M derived: sum of 3 quarters · filed 2018-02-15 | $45.78M 10-K · filed 2018-02-15 |
| 2015-09-30 | $11.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $22.03M derived: sum of 2 quarters · filed 2016-11-03 | $30.26M 10-Q · filed 2016-11-03 | $43.70M derived: sum of 4 quarters · filed 2017-02-15 |
| 2015-06-30 | $10.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $18.41M 10-Q · filed 2016-08-04 | $31.85M derived: sum of 3 quarters · filed 2017-02-15 | $38.20M derived: sum of 4 quarters · filed 2017-02-15 |
| 2015-03-31 | $8.24M 10-Q · filed 2016-05-04 | $21.67M derived: sum of 2 quarters · filed 2017-02-15 | $28.03M derived: sum of 3 quarters · filed 2017-02-15 | $35.71M derived: sum of 4 quarters · filed 2017-02-15 |
| 2014-12-31 | $13.44M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-15 | $19.79M derived: sum of 2 quarters · filed 2017-02-15 | $27.47M derived: sum of 3 quarters · filed 2017-02-15 | $33.06M 10-K · filed 2017-02-15 |
| 2014-09-30 | $6.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $14.03M derived: sum of 2 quarters · filed 2015-11-09 | $19.62M 10-Q · filed 2015-11-09 | $25.03M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-30 | $7.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $13.27M 10-Q · filed 2015-08-07 | $18.68M derived: sum of 3 quarters · filed 2016-02-12 | $27.52M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-31 | $5.59M 10-Q · filed 2015-05-08 | $11.00M derived: sum of 2 quarters · filed 2016-02-12 | $19.84M derived: sum of 3 quarters · filed 2016-02-12 | $23.22M derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-31 | $5.41M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $14.25M derived: sum of 2 quarters · filed 2016-02-12 | $17.63M derived: sum of 3 quarters · filed 2016-02-12 | $20.70M 10-K · filed 2016-02-12 |
| 2013-09-30 | $8.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $12.22M derived: sum of 2 quarters · filed 2014-11-06 | $15.30M 10-Q · filed 2014-11-06 | $18.02M derived: sum of 4 quarters · filed 2015-02-13 |
| 2013-06-30 | $3.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $6.45M 10-Q · filed 2014-08-08 | $9.17M derived: sum of 3 quarters · filed 2015-02-13 | $12.56M derived: sum of 4 quarters · filed 2015-02-13 |
| 2013-03-31 | $3.08M 10-Q · filed 2014-05-09 | $5.80M derived: sum of 2 quarters · filed 2015-02-13 | $9.18M derived: sum of 3 quarters · filed 2015-02-13 | $12.28M derived: sum of 4 quarters · filed 2015-02-13 |
| 2012-12-31 | $2.72M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | $6.11M derived: sum of 2 quarters · filed 2015-02-13 | $9.20M derived: sum of 3 quarters · filed 2015-02-13 | $12.36M 10-K · filed 2015-02-13 |
| 2012-09-30 | $3.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $6.48M derived: sum of 2 quarters · filed 2013-11-07 | $9.64M 10-Q · filed 2013-11-07 | $13.72M derived: sum of 4 quarters · filed 2014-02-20 |
| 2012-06-30 | $3.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $6.25M 10-Q · filed 2013-08-09 | $10.33M derived: sum of 3 quarters · filed 2014-02-20 | $14.59M derived: sum of 4 quarters · filed 2014-02-20 |
| 2012-03-31 | $3.16M 10-Q · filed 2013-05-07 | $7.24M derived: sum of 2 quarters · filed 2014-02-20 | $11.50M derived: sum of 3 quarters · filed 2014-02-20 | $15.71M derived: sum of 4 quarters · filed 2014-02-20 |
| 2011-12-31 | $4.08M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | $8.34M derived: sum of 2 quarters · filed 2014-02-20 | $12.55M derived: sum of 3 quarters · filed 2014-02-20 | $16.68M 10-K · filed 2014-02-20 |
| 2011-09-30 | $4.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | $8.47M derived: sum of 2 quarters · filed 2012-11-05 | $12.59M 10-Q · filed 2012-11-05 | $16.81M derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-06-30 | $4.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $8.34M 10-Q · filed 2012-08-08 | $12.55M derived: sum of 3 quarters · filed 2013-02-19 | $17.06M derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-03-31 | $4.12M 10-Q · filed 2012-05-03 | $8.33M derived: sum of 2 quarters · filed 2013-02-19 | $12.85M derived: sum of 3 quarters · filed 2013-02-19 | $17.91M derived: sum of 4 quarters · filed 2013-02-19 |
| 2010-12-31 | $4.21M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | $8.72M derived: sum of 2 quarters · filed 2013-02-19 | $13.79M derived: sum of 3 quarters · filed 2013-02-19 | $19.12M 10-K · filed 2013-02-19 |
| 2010-09-30 | $4.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $9.58M derived: sum of 2 quarters · filed 2011-11-03 | $14.91M 10-Q · filed 2011-11-03 | $18.85M derived: sum of 4 quarters · filed 2012-02-13 |
| 2010-06-30 | $5.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-03 | $10.39M 10-Q · filed 2011-08-03 | $14.34M derived: sum of 3 quarters · filed 2012-02-13 | $19.97M derived: sum of 4 quarters · filed 2012-02-13 |
| 2010-03-31 | $5.33M 10-Q · filed 2011-05-05 | $9.27M derived: sum of 2 quarters · filed 2012-02-13 | $14.90M derived: sum of 3 quarters · filed 2012-02-13 | |
| 2009-12-31 | $3.94M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-13 | $9.57M derived: sum of 2 quarters · filed 2012-02-13 | $19.73M 10-K · filed 2012-02-13 | |
| 2009-09-30 | $5.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-04 | $15.79M 10-Q · filed 2010-11-04 | ||
| 2009-06-30 | $10.15M 10-Q · filed 2010-08-05 | |||
| 2008-12-31 | $18.03M 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |